The Advisory & Directorial Team at Causeway Therapeutics provides strategic guidance and oversight for the company's clinical-stage biopharmaceutical initiatives. They ensure that development and clinical trials of novel microRNA therapies align with both regulatory standards and the company’s long-term objectives in treating musculoskeletal and age-related diseases.